Abu dhabi: Yas Clinic Khalifa City, in collaboration with Abu Dhabi Stem Cells Center (ADSCC), has entered into a strategic Memorandum of Understanding (MoU) with Ohio University, marking a pivotal advancement in international scientific collaboration and research in the domains of cellular and gene therapy.

According to Emirates News Agency, the MoU was revealed during a scientific exchange event that united medical leaders, researchers, and experts to discuss the burgeoning field of stem cell innovation and advanced cellular therapies. The event featured discussions on the ADSCC stem cell program and the potential therapeutic applications extending beyond cancer treatment.

The partnership aims to bolster research cooperation, facilitate knowledge exchange, and foster the development of innovative treatments in hematology, oncology, and regenerative medicine. This strategic collaboration positions Abu Dhabi as a key regional hub for advanced medical research and patient-focused innovation.

Dr. Maysoon Al Karam, Chief Medical Officer at Yas Clinic - Khalifa City, stated that the collaboration underscores their commitment to advancing medical knowledge and translating research into clinical applications. By partnering with ADSCC and Ohio University, they aim to enrich their academic ecosystem and foster innovation in cell and gene therapy that will benefit patients and future generations.

The event also highlighted global advancements in CAR-T and cellular therapies, underscoring the significance of collaborative research and local clinical application in accelerating treatment development.

Mubasher Maqbul, acting CEO of Yas Clinic, acknowledged the partnership as a significant step in reinforcing their dedication to innovation, research, and academic collaboration. This alliance is expected to pave new pathways for scientific discovery, enhancing patient care and bringing advanced therapies to the communities they serve.

Dr. Mohamed Abuhaleeqa, Consultant in Hematology and Bone Marrow Transplant and Chair of Academic Affairs at Yas Clinic- Khalifa City, emphasized that research collaboration is fundamental to modern medicine. The alliance aims to create a robust ecosystem of clinical learning and scientific exchange, expediting the development of advanced cellular therapies and improving patient outcomes across the region.

The signing ceremony reflects the unified vision of Yas Clinic, ADSCC, and Ohio University to establish sustainable academic partnerships, drive clinical innovation, and contribute to the global advancement of regenerative and precision medicine.